Thermo Fisher Scientific Inc. $TMO, one of the world’s largest life sciences and biotechnology companies, is reportedly seeking to sell its diagnostics business for approximately $4 billion USD, according to the Financial Times. The move signals a broader strategy to divest lower-margin and slower-growing segments in favor of focusing on core areas such as contract drug manufacturing and advanced analytical technologies.